You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/RHRg3ji6Nf6v/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Report Content

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

Thank you for submitting your report

We will investigate and take the appropriate action.

Add to Playlist

UK Column News - 2nd November 2022 - Huge money in jabs—even before people are born

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 14:56 UTC on November 3rd, 2022.

#immunity
#in
#utero

UKColumnExtracts

subscribers

Your platform for uncensored ideas. BitChute Premium.

BitChute Advertisement

- MHRA Board Meeting ticket booking time is here again
- Independent: Dozens of children vaccine-overdosed
- Health Service Journal (HSJ) Patient Safety Congress: £199 to hear the Patient Safety Commissioner, Dr Henrietta Hughes
- Citeline: the new name for Datamonitor pharmaceutical consultancy/intelligence
- Cambridge Cluster: more magic than medicine
- VacZine Analytics helps its clients predict the market for immune-based therapies
- Graphs show exponential growth of jab industry: trebled to £60 billion
- Cambridgeshire Live: Norovirus scare in Peterborough (see also Debi Evans' blog)
- Express: Young children flu season warning
- Forbes: First RSV vaccine on the horizon—Pfizer trial
- EndPoints News: Pfizer declares first-ever Phase III success for RSV vaccine in infants—immunity in utero
Appeal to viewers: Who is VacZine Analytics' John Savopoulos (pharmaceutical intelligence)? Is he related to the other Savopoulos noted at the company? What is his background?

Sources: https://www.ukcolumn.org/video/uk-column-news-2nd-november-2022
Archive on demand, UKC articles, latest discussions, community groups and more: https://community.ukcolumn.org/

LESS